Bracco Imaging SpA, a global leader in diagnostic imaging, and Subtle Medical, Inc., a leading innovator in artificial intelligence (AI), have entered into a global agreement in the field of magnetic resonance imaging ( MRI) closed. This global agreement will begin primarily in the United States, where Bracco Imaging will distribute its portfolio of products and services through its subsidiary Bracco Diagnostics Inc.
Contrast-enhanced MRI involves the use of contrast agents to highlight specific tissues or abnormalities, allowing for better visualization and more detailed information. Exploring and harnessing the power of AI in this context could lead to more precise and efficient image interpretation, improved diagnostic capabilities and optimized patient care. This strategic partnership allows Bracco Imaging and Subtle Medical to leverage each other’s intellectual property to make progress toward these ambitious goals.
Fulvio Renoldi Bracco, Vice Chairman and Managing Director of Bracco Imaging SpA , commented: “The combination of Bracco’s expertise in contrast imaging and Subtle Medical’s deep learning technology applied to MRI imaging will undoubtedly benefit physicians and their patients. Through this partnership, we will strive to redefine the boundaries of diagnostic precision and efficiency, unlocking new opportunities and creating additional value to our already unique MRI portfolio.”
“Subtle Medical is pleased to partner with a global industry leader in the development and commercialization of contrast agents like Bracco,” said Enhao Gong , CEO of Subtle Medical, Inc. “This agreement represents a significant milestone for both companies as we join forces to to support healthcare professionals and improve outcomes for patients worldwide with Subtle Medical’s platform and innovative range of AI products for MRI and beyond.”
SOURCE: PRNewswire
